These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34768374)

  • 1. Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases.
    Ruiz-Sala P; Peña-Quintana L
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.
    Sklirou E; Alodaib AN; Dobrowolski SF; Mohsen AA; Vockley J
    Front Genet; 2020; 11():598760. PubMed ID: 33584796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
    Wang S; Leng J; Diao C; Wang Y; Zheng R
    J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid oxidation disorders.
    Merritt JL; Norris M; Kanungo S
    Ann Transl Med; 2018 Dec; 6(24):473. PubMed ID: 30740404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
    Yamada K; Taketani T
    J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inborn Errors of Mitochondrial Fatty Acid Oxidation: Overview from a Clinical Perspective.
    Yoo HW
    J Lipid Atheroscler; 2021 Jan; 10(1):1-7. PubMed ID: 33537249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment.
    Wanders RJA; Visser G; Ferdinandusse S; Vaz FM; Houtkooper RH
    J Lipid Atheroscler; 2020 Sep; 9(3):313-333. PubMed ID: 33024728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
    Suyama T; Shimura M; Fushimi T; Kuranobu N; Ichimoto K; Matsunaga A; Takayanagi M; Murayama K
    Mol Genet Metab Rep; 2020 Sep; 24():100610. PubMed ID: 32509533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Clinical Management of Long-chain Fatty-acid Oxidation Disorders: A Review.
    Baker JJ; Burton BK
    touchREV Endocrinol; 2021 Nov; 17(2):108-111. PubMed ID: 35118456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.
    Knottnerus SJG; Bleeker JC; Wüst RCI; Ferdinandusse S; IJlst L; Wijburg FA; Wanders RJA; Visser G; Houtkooper RH
    Rev Endocr Metab Disord; 2018 Mar; 19(1):93-106. PubMed ID: 29926323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.
    El-Gharbawy A; Vockley J
    Pediatr Clin North Am; 2018 Apr; 65(2):317-335. PubMed ID: 29502916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.